Clinical Trial Update: A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KDT-3594 in Japanese patients with early Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KDT-3594

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED